This document provides an overview of various topics related to abdominal radiology. It discusses abnormal bowel gas patterns, small bowel obstruction, sigmoid colon volvulus, CT and MRI techniques for imaging the liver, autosomal dominant polycystic liver disease, congenital hepatic hemangioma, focal nodular hyperplasia, hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases, hepatic metastases, and using dynamic vascular patterns in ultrasound to distinguish benign from malignant liver lesions. The document provides examples and images related to these various abdominal and liver conditions.
65. Prenatal US showing a large intra-hepatic cyst, and a normal gall bladder (*). CT
scan at births confirmed a very large hepatic cyst and the normal gall bladder (*).
66. Prenatal MRI confirmed hepatic cyst located in segment IV and postnatal evolution in
MRI realized preoperatively at 6 weeks of life. Postnatal US illustrated the rapid
growing of hepatic cyst between days 2 of life (D2) and the first months of life (M1).
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86. Hepatic hemangioma lesion
at prenatal ultrasound.
Hepatic lesion at postnatal ultrasound;
marked, peripheral Doppler blood flow.
92. The caudate lobe lesion (arrowheads) presents subtle hypersignal on T2-weighted sequence and signal loss on T1-weighted
out-of-phase sequence caused by the presence of intralesional fat. Such a lesion shows intense and homogeneous contrast
uptake in the arterial-phase, with decay in the portal and delayed phases, presenting greater Hepatobiliary contrast uptake
than the adjacent parenchyma, suggesting FNH as the first diagnostic hypothesis. Considering that the presence of
intralesional fat in NFH is rare, the patient will be maintained under imaging follow-up. The lesions in segments VII and VIII
(arrows) are similar, with marked hypersignal on T2-weighted, hyposignal on T1-weighted sequence, and nodular,
peripheral and discontinuous uptake in the arterial phase, a characteristic of hemangiomas.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106. Multiple, well-defined focal hypervascular lesions, with intermediate signal intensity on T2-
weighted sequence, with poor lesion-organ contrast-enhancement. However, the presence of
intra lesional fat was detected on out-of-phase T1-weighted sequence. The presence of intra
lesional fat is not usually found in FNH and suggests the diagnosis of adenoma – adenomatosis
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
141.
142. Small HCC seen only in arterial phase in a patient with cirrhosis.
143. NECT, arterial and portal venous phase in a patient with
Hepatitis C with two lesions in the liver (arrows).
144.
145. LEFT: Diffusely enhancing tumor thrombus in HCC with portal vein
invasion. RIGHT: Tumor thrombus with vessels within the thrombus.
146.
147.
148.
149.
150.
151.
152.
153. Large HCC with mozaik pattern in a non cirrhotic patient.
154.
155. Two liver nodules are seen in the segment VIII (arrows) as well as a larger nodule, in the
segment VI (arrowheads), all of them contrast-enhanced in the arterial-phase, washout in
the delayed-phase, and without uptake in the hepatobiliary-phase, characterizing HCCs.
169. Colorectal metastasis with hyper-(rim)/hypo-/hypo- appearance. (a) Arterial phase image
shows a homogeneously enhanced hyperattenuating rim (arrows). (b) Portal phase image
shows that the lesion was homogeneously hypoattenuating. (c) Equilibrium phase image
shows that the periphery of the metastasis is hypoattenuating (arrows) relative to the
enhanced center of the lesion and the surrounding liver parenchyma.
178. Analysis of dynamic vascular pattern(DVP) in ultrasound can be used
to distinguish benign from malignant flow patterns in focal liver lesions.
179. Four clinical cases show how DVP parametric images allow facilitated lesion characterization
as benign or malignant in four typical clinical examples, with malignant lesions appearing in
red, unlike benign lesions which are green or yellow-green in appearance.